Establishment and characterization of a novel human malignant peripheral nerve sheath tumor cell line, FMS-1, that overexpresses epidermal growth factor receptor and cyclooxygenase-2

Virchows Archiv

Volumn 455, Issue 6, 2009, Pages 517-526

  Hakozaki, Michiyuki ^a   Hojo, Hiroshi ^a   Sato, Michiko ^a   Tajino, Takahiro ^a   Yamada, Hitoshi ^a   Kikuchi, Shinichi ^a   Abe, Masafumi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2; Epidermal growth factor receptor; FMS 1 cell line; Malignant peripheral nerve sheath tumor; Neurofibromatosis type 1

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR;

AGED; ARTICLE; BIOLOGICAL TRAIT; BRACHIAL PLEXUS; CANCER GRAFT; CASE REPORT; CONTROLLED STUDY; CYTOGENETICS; EXON; FEMALE; FIBROSARCOMA; HUMAN; MICROSCOPY; MOLECULAR GENETICS; NERVE SHEATH TUMOR; PHYSICAL EXAMINATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SPINDLE CELL; TUMOR CELL; TUMOR CELL LINE;

AGED; ANIMALS; BRACHIAL PLEXUS NEUROPATHIES; CELL LINE, TUMOR; CYCLOOXYGENASE 2; FEMALE; GENES, P53; HUMANS; MICE; NEOPLASM TRANSPLANTATION; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 73449100423     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0848-1     Document Type: Article

References (49)

1. Woodruff JM, Kourea HP, Louis DN et al (2000) Malignant peripheral nerve sheath tumour (MPNST). In: Kleihues P, Cavenee WK (eds) World Health Organization classification of tumours. Tumours of the nervous system. IARC Press, Lyon, pp 172-174
2. Weiss SW, Goldblum JR (2007) Malignant tumors of the peripheral nerves. In: Weiss SW, Goldblum JR (eds) Enzinger and Weiss's soft tissue tumors, 5th edn. Mosby/Elsevier, Philadelphia, pp 903-917
3. SR Grobmyer JD Reith A Shahlaee, et al. 2008 Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations J Surg Oncol 97 340 349 10.1002/jso.20971 18286466 (Pubitemid 351358582)
4. I Ono I Ishiwata T Nakaguchi, et al. 1989 Establishment and characterization of a human malignant schwannoma cell line (HKMS) Hum Cell 2 272 277 2519215 (in Japanese with English abstract)
5. Y Nagashima Y Ohaki Y Tanaka, et al. 1990 Establishment of an epithelioid malignant schwannoma cell line (YST-1) Virchows Arch [B] 59 321 327 10.1007/BF02899420
6. JE Reynolds JA Fletcher CH Lytle, et al. 1992 Molecular characterization of a 17q11.2 translocation in a malignant schwannoma cell line Hum Genet 90 450 456 10.1007/BF00220476 1483704
7. S Imaizumi T Motoyama A Ogose, et al. 1998 Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1 Virchows Arch 433 435 441 10.1007/s004280050271 9849858 (Pubitemid 28522032)
8. H Sonobe T Takeuchi M Furihata, et al. 2000 A new human malignant peripheral nerve sheath tumour-cell line, HS-sch-2, harbouring p53 point mutation Int J Oncol 17 347 352 10891546
9. M Aoki K Nabeshima J Nishio, et al. 2006 Establishment of three malignant peripheral nerve sheath tumor cell lines, FU-SFT8611, 8710 and 9817: conventional and molecular cytogenetic characterization Int J Oncol 29 1421 1428 17088980
10. CDM Fletcher P Dal Cin I de Wever, et al. 1999 Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group Am J Pathol 154 1841 1847 10362810
11. Fletcher CDM (2000) Peripheral neuroectodermal tumors. In: Fletcher CDM (ed) Diagnostic histopathology of tumors, 2nd edn. Churchill Livingstone, London, pp 1695-1698
12. Y Murakami K Hayashi T Sekiya 1991 Detection of aberrations the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis Cancer Res 51 3356 3361 2054775
13. M Hakozaki H Hojo M Sato, et al. 2006 Establishment and characterization of a new cell line, FRTK-1, derived from human malignant rhabdoid tumor of the kidney, with overexpression of epidermal growth factor receptor and cyclooxygenase-2 Oncol Rep 16 265 271 16820901
14. M Hakozaki H Hojo M Sato, et al. 2006 Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2 Anticancer Res 26 3393 3401 17094458
15. SL Carroll MS Stonecypher 2004 Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations J Neuropathol Exp Neurol 63 1115 1123 15581179
16. I Bottillo T Ahlquist H Brekke, et al. 2009 Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours J Pathol 217 693 701 10.1002/path.2494 19142971
17. E Legius DA Marchuk FS Collins, et al. 1993 Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis Nat Genet 3 122 126 10.1038/ng0293-122 8499945 (Pubitemid 23079793)
18. AG Menon KM Anderson VM Riccardi, et al. 1990 Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis Proc Natl Acad Sci USA 87 5435 5439 10.1073/pnas.87.14.5435 2142531 (Pubitemid 20260195)
19. E Legius H Dierick R Wu, et al. 1994 TP53 mutations are frequent in malignant NF1 tumors Genes Chromosomes Cancer 10 250 255 10.1002/gcc.2870100405 7522538 (Pubitemid 24238432)
20. RA Lothe A Slettan G Saeter, et al. 1995 Alterations at chromosome 17 loci in peripheral nerve sheath tumors J Neuropathol Exp Neurol 54 65 73 10.1097/00005072-199501000-00008 7815081
21. RS Bridge Jr JA Bridge JR Neff, et al. 2004 Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study J Clin Pathol 57 1172 1178 10.1136/jcp.2004.019026 15509679 (Pubitemid 39486524)
22. S Birindelli F Perrone M Oggionni, et al. 2001 Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors Lab Invest 81 833 844 11406645
23. C Mawrin E Kirches C Boltze, et al. 2002 Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors Virchows Arch 440 610 615 10.1007/s00428-001-0550-4 12070601 (Pubitemid 34809693)
24. AM Davidoff JC Pence NA Shorter, et al. 1992 Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines Oncogene 7 127 133 1741160
25. R Villuendas MA Piris P Algara, et al. 1993 The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations Blood 82 3151 3156 8219204
26. P Lepelley C Preudhomme M Vanrumbeke, et al. 1994 Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis Leukemia 8 1342 1349 8057671
27. RI Nicholson JM Gee ME Harper 2001 EGFR and cancer prognosis Eur J Cancer 37 S9 S15 10.1016/S0959-8049(01)00231-3 11597399
28. T Holbro G Civenni N Hynes 2003 The ErbB receptors and their role in cancer progression Exp Cell Res 284 99 110 10.1016/S0014-4827(02)00099-X 12648469 (Pubitemid 36331969)
29. Y Dobashi N Takei S Suzuki, et al. 2004 Aberration of epidermal growth factor receptor expression in bone and soft-tissue tumors: protein overexpression, gene amplification and activation of downstream molecules Mod Pathol 17 1497 1505 10.1038/modpathol.3800218 15254554 (Pubitemid 39627076)
30. T Yamamoto I Fujita T Akisue, et al. 2004 Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues Anticancer Res 24 1307 1310 15154665 (Pubitemid 38624979)
31. D Beech RE Pollock R Tsan, et al. 1998 Epidermal growth factor receptor and insulin-like growth factor-I receptor expression and function in human soft-tissue sarcoma cells Int J Oncol 12 329 336 9458358
32. A Abdiu TM Walz BK Nishikawa, et al. 1998 Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha and their receptors Eur J Cancer 34 2094 2100 10.1016/S0959- 8049(98)00247-0 10070317 (Pubitemid 28546948)
33. H Tawbi D Thomas DR Lucas, et al. 2008 Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors Oncologist 13 459 466 10.1634/theoncologist.2007-0166 18448562 (Pubitemid 351679927)
34. N Holtkamp E Malzer J Zietsch, et al. 2008 EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy Neuro Oncol 10 946 957 10.1215/15228517-2008-053 18650488
35. JR Vane YS Bakhle RM Botting 1998 Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38 97 120 10.1146/annurev.pharmtox.38.1.97 9597150
36. RN Dubois SB Abramson L Crofford, et al. 1998 Cyclooxygenase in biology and disease FASEB J 12 1063 1073 9737710
37. S Gately WW Li 2004 Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy Semin Oncol 31 2 11 10.1053/j.seminoncol.2004. 03.040 15179620
38. H Yamashita M Osaki S Honjo, et al. 2003 A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line Anticancer Res 23 4671 4676 14981912
39. T Naruse Y Nishida K Hosono, et al. 2006 Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes Carcinogenesis 27 584 592 10.1093/carcin/bgi240 16219634 (Pubitemid 43378898)
40. M Hakozaki H Hojo S Kikuchi, et al. 2007 Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1) Oncol Rep 17 169 173 17143495
41. T Naruse Y Nishida N Ishiguro 2007 Synergistic effects of meloxicam and conventional cytotoxic drugs in human MG-63 osteosarcoma cells Biomed Pharmacother 61 338 346 10.1016/j.biopha.2007.02.011 17395421 (Pubitemid 47187633)
42. EJ Lee EM Choi SR Kim, et al. 2007 Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells Exp Mol Med 39 469 476 17934334
43. B Liu ZL Shi J Feng, et al. 2008 Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt Cell Biol Int 32 494 501 10.1016/j.cellbi.2007.10.008 18078766
44. AJ Dannenberg SM Lippman JR Mann, et al. 2005 Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention J Clin Oncol 23 254 266 10.1200/JCO.2005.09.112 15637389 (Pubitemid 46206877)
45. SM Lippman N Gibson K Subbaramaiah, et al. 2005 Combined targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways Clin Cancer Res 11 6097 6099 10.1158/1078-0432.CCR-05-1217 16144906 (Pubitemid 41262933)
46. G Tortora R Caputo V Damiano, et al. 2003 Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect Clin Cancer Res 9 1566 1572 12684433
47. Z Chen X Zhang M Li, et al. 2004 Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck Clin Cancer Res 10 5930 5939 10.1158/1078-0432.CCR-03-0677 15355926 (Pubitemid 39180975)
48. X Zhang ZG Chen MS Choe, et al. 2005 Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model Clin Cancer Res 11 6261 6269 10.1158/1078-0432.CCR-04-2102 16144930 (Pubitemid 41262957)
49. D Melisi R Caputo V Damiano, et al. 2005 Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer Endocr Relat Cancer 12 1051 1058 10.1677/erc.1.01061 16322342 (Pubitemid 41815796)